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to view.1 Atherosclerotic Plaque Characteristics by CT Angiography Identify Coronary Lesions
That Cause Ischemia: A Direct Comparison to Fractional Flow Reserve
Hyung-Bok Park, Ran Heo, Bríain ó Hartaigh, Iksung Cho, Heidi Gransar,
Ryo Nakazato, Jonathon Leipsic, G.B. John Mancini, Bon-Kwon Koo, Hiromasa Otake,
Matthew J. Budoff, Daniel S. Berman, Andrejs Erglis, Hyuk-Jae Chang, James K. MinVINI : While computed tomography (CT)-based atherosclerotic plaque characteristics (APCs), such as
aggregate plaque volume % (%APV), positive remodeling (PR), low attenuation plaque (LAP) and spotty
calciﬁcation (SC) are associated with future coronary syndromes, their relationship to ischemia is unclear.
VIDI : In this prospective multicenter trial of 252 patients with suspected coronary artery disease (CAD)
undergoing both CT and fractional ﬂow reserve, a 4.5  higher odds of ischemia was observed for 1 and a
13.2  higher odds of ischemia for $2 (odds ratio 13.2, p < 0.001) APCs. PR was associated with all
ischemia-causing lesions, while %APV and LAP was only associated with ischemia-causing lesions >50%.
VICI : This study establishes that, independent and incremental to stenosis severity, plaque burden, and
APCs by CT improves identiﬁcation, discrimination, and reclassiﬁcation of coronary artery lesions that
cause ischemia. Characterization of APCs by CT is likely to become an important adjunctive tool for risk-
stratiﬁcation of patients with suspected CAD.11 n EDITORIAL COMMENT Diagnostic Coronary Angiography Is Getting Old!
Antonio Colombo, Vasileios F. Panoulas14 Regurgitant Volume Informs Rate of Progressive Cardiac Dysfunction in
Asymptomatic Patients With Chronic Aortic or Mitral Regurgitation
Kenya Kusunose, Paul C. Cremer, Rayji S. Tsutsui, Richard A. Grimm,
James D. Thomas, Brian P. Grifﬁn, Zoran B. PopovicVINI : Current guidelines recommend frequent surveillance echocardiography in asymptomatic patients
with moderate to severe aortic regurgitation (AR) or mitral regurgitation (MR). Questions remain as to
whether the severity of the regurgitant lesion can guide surveillance echocardiography.
VIDI : In this observational cohort of 130 asymptomatic AR and 130 asymptomatic MR patients with
moderate regurgitant volumes, echocardiographic parameters were stable in the majority of patients
during a 3-year follow-up. With severe regurgitant volumes, progressive cardiac dysfunction ensued at a
similar rate and in a similar manner regardless of the etiology for regurgitation.
VICI : These data endorse less frequent interval echocardiography in stable, asymptomatic patients with
moderate MR or AR as assessed by regurgitant volume but are preliminary and should be considered as
hypothesis-generating. A larger prospective multicenter validation study with more complete follow-up is
needed before screening guidelines can be changed.24 n EDITORIAL COMMENT Valve Regurgitation With LV Dysfunction:
How Did We Get There?
Maurice Enriquez-SaranoCONTINUED ON PAGE A-11
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JANUARY 2015 VOLUME 8, NUMBER 126 Impact of Plasma Lp-PLA2 Activity on the Progression of Aortic Stenosis:
The PROGRESSA Study
Romain Capoulade, Ablajan Mahmut, Lionel Tastet, Marie Arsenault,
Élisabeth Bédard, Jean G. Dumesnil, Jean-Pierre Després, Éric Larose,
Benoit J. Arsenault, Yohan Bossé, Patrick Mathieu, Philippe PibarotVINI : Lipoprotein–associated phospholipase A2 (Lp-PLA2) is highly expressed in stenotic aortic valves and
is increased in patients with aortic stenosis.
VIDI : In this prospective sub-analysis of the PROGRESSA (Metabolic Determinants of the Progression of
Aortic Stenosis) study of 183 patients, elevated Lp-PLA2 activity was independently associated with a
signiﬁcantly faster aortic stenosis (AS) progression rate (p ¼ 0.01) in the subset of patients with mild AS
(n ¼ 123), but not in patients with moderate or severe AS.
VICI : These ﬁndings support the role of Lp-PLA2 in the early pathogenesis of AS, providing a strong
impetus for a randomized trial of an Lp-PLA2 inhibitor in patients with early stages of disease.34 n EDITORIAL COMMENT Lipoprotein-Associated Phospholipase A2 and Aortic Stenosis:
Biomarker or New Target for an Old Foe?
Donald Heistad, Hardik Doshi37 Native T1 in Discrimination of Acute and Convalescent Stages in Patients With
Clinical Diagnosis of Myocarditis: A Proposed Diagnostic Algorithm Using CMR
Rocio Hinojar, Lucy Foote, Eduardo Arroyo Ucar, Thomas Jackson, Andrew Jabbour,
Chung-Yao Yu, Jane McCrohon, David M. Higgins, Gerry Carr-White, Manuel Mayr,
Eike Nagel, Valentina O. PuntmannVINI : Diagnosis of acute viral myocarditis relies heavily on cardiac magnetic resonance (CMR) techniques,
but use of CMR in tracking changes in evolution of myocarditis is less well understood..
VIDI : Subjects with a clinical diagnosis of viral myocarditis (n ¼ 165) underwent routine CMR protocol
along with pre- and post-contrast T1 mapping. Native T1 mapping could discriminate between health and
disease as well as between acute and convalescent myocarditis. Native T1 values were predictive of acute
myocarditis while a combination of T1 and LGE were useful in the convalescent stage. An algorithm
incorporating this information was predictive in a validation set of patients.
VICI : Native T1 mapping in viral myocarditis allows for improved discrimination of various stages of the
disease.47 n EDITORIAL COMMENT Myocardial T1: The Rise of a Novel Biomarker Continues
Matthias G. FriedrichCONTINUED ON PAGE A-12
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JANUARY 2015 VOLUME 8, NUMBER 150 11C-Pittsburgh B PET Imaging in Cardiac Amyloidosis
Seung-Pyo Lee, Eun Seong Lee, Hongyoon Choi, Hyung-Jun Im, Youngil Koh,
Min-Ho Lee, Ji-Hyun Kwon, Jin Chul Paeng, Hyung-Kwan Kim, Gi Jeong Cheon,
Yong-Jin Kim, Inho Kim, Sung-Soo Yoon, Jeong-Wook Seo, Dae-Won SohnVINI : 11C -Pittsburgh B (PiB) positron emission tomography (PET)/computed tomography (CT) can detect
amyloid deposits in the brain. Whether PiB can also identify cardiac amyloidosis has not been established.
VIDI : In this pilot study of 22 patients with monoclonal gammopathy and suspected cardiac amyloidosis,
11C -PiB PET/CT uptake ratio was signiﬁcantly different between those with biopsy-proved cardiac amy-
loidosis versus those without, despite minimal differences in echocardiography. This ratio was also dif-
ferent between the chemotherapy-naïve group and the previous chemotherapy group.
VICI : This preliminary study demonstrates that 11C-PiB PET/CT may be a good surrogate marker of active
light chain deposition in themyocardium,whichmay provide a newnoninvasivemodality for assessing cardiac
amyloidosis. It prompts the elaboration of larger prospective validation study to conﬁrm these ﬁndings.60 n EDITORIAL COMMENT Developing Imaging Biomarkers for Myocardial Involvement
in Amyloidosis: Challenge and Opportunity
James E. Udelson63 Macrophages and Intravascular OCT Bright Spots: A Quantitative Study
Jennifer E. Phipps, Deborah Vela, Taylor Hoyt, David L. Halaney, J. Jacob Mancuso,
L. Maximilian Buja, Reto Asmis, Thomas E. Milner, Marc D. FeldmanVINI : Use of intravascular optical coherence tomography (IVOCT) offers superior resolution when char-
acterizing atherosclerotic plaque. The presence of bright spots, historically thought to represent macro-
phages, lacks speciﬁcity. In this study, the authors posit that bright spots can come from other etiologies
and simply represent a sharp change in the indices of refraction.
VIDI : After developing a quantitative bright spot detection algorithm and applying it to IVOCT images
from 14 human coronary arteries, macrophage-rich areas were identiﬁed as bright spots in only 23% of
regions. Additional etiologies for bright spots included interfaces between calcium and ﬁbrous tissue
(10%), calcium and lipid (5%), and ﬁbrous cap and lipid pool (3%).
VICI : IVOCT canbe a valuable clinical tool but algorithms such as this onemaybe necessary to standardize image
interpretation and improve diagnostic accuracy. This work also demonstrates how emerging technologies con-
stantly need to undergo revision and review in order to maintain a high level of sensitivity and speciﬁcity.73 n EDITORIAL COMMENT OCT Imaging of Macrophages: A Bright Spot in the Study
of Inﬂammation in Human Atherosclerosis
Guillermo J. TearneyCONCEPTS ON THE
VERGE OF TRANSLATION
76 Association of Myocardial T1-Mapping CMR With Hemodynamics and RV Performance
in Pulmonary Hypertension
Ana García-Álvarez, Inés García-Lunar, Daniel Pereda, Rodrigo Fernández-Jimenez,
Javier Sánchez-González, Jesús G. Mirelis, Mario Nuño-Ayala, Damian Sánchez-Quintana,
Leticia Fernández-Friera, Jose M. García-Ruiz, Gonzalo Pizarro, Jaume Agüero,
Paula Campelos, Manuel Castellá, Manel Sabaté, Valentin Fuster, Javier Sanz, Borja IbañezCONTINUED ON PAGE A-13
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83 Pulmonary Hypertension in Valvular Disease: A Comprehensive Review on
Pathophysiology to Therapy From the HAVEC Group
Julien Magne, Philippe Pibarot, Partho P. Sengupta, Erwan Donal, Raphael Rosenhek,
Patrizio LancellottiIMAGING VIGNETTE 100 MDCT Assessment of Mechanical Circulatory Support Device Complications
Rey P. Vivo, Mahwash Kassi, Jerry D. Estep, Arvind Bhimaraj, Barry H. Trachtenberg,
Carlos M. Orrego, Matthias Loebe, Brian A. Bruckner, Faisal Nabi, John J. Mahmarian,
William A. Zoghbi, Su Min ChangLETTERS TO THE EDITOR 103 A Novel Approach to Neonatal Management of Tetralogy of Fallot, With Pulmonary
Atresia, and Multiple Aortopulmonary Collaterals
Justin R. Ryan, Tabitha G. Moe, Randy Richardson, David H. Frakes, John J. Nigro,
Stephen Pophal104 Mechanical Dispersion by Strain Echocardiography: A Predictor of Ventricular
Arrhythmias in Subjects With Lamin A/C Mutations
Kristina H. Haugaa, Nina E. Hasselberg, Thor Edvardsen106 Abnormal Myocardial Perfusion in Kawasaki Disease Convalescence
Konstantinos Bratis, Amedeo Chiribiri, Tarique Hussain, Thomas Krasemann,
Marcus Henningsson, Alkystis Phinikaridou, Sophie Mavrogeni, Rene Botnar,
Eike Nagel, Reza Razavi, Gerald Greil108 Noninvasive Evaluation of Bone-Forming Activity Within the Calciﬁed Atherosclerotic
Lesions by Tc 99m HMDP Scintigraphy
Nobuhiro Tahara, Atsuko Tahara, Akihiro Honda, Yoshikazu Nitta, Sachiyo Igata,
Yukihiko Nakamura, Yasuharu Takeuchi, Hidetoshi Akashi, Hiroyuki Tanaka,
Motohiro Morioka, Jagat Narula, Sho-ichi Yamagishi, Yoshihiro Fukumoto109 Diagnostic Value of Quantitative CMR in Patients Suspected of Having Myocarditis:
A Question of Timing
Julian A. Luetkens, Jonas Doerner, Hans Schild, Claas P. Naehlen REPLYUlf K. Radunski, Gunnar K. Lund, Kai MuellerleileCONTINUED ON PAGE A-14
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JANUARY 2015 VOLUME 8, NUMBER 1EDITORIAL PERSPECTIVE 111 Discordance Between Ischemia and Stenosis, or PINSS and NIPSS:
Are We Ready for New Vocabulary?
Amir Ahmadi, Annapoorna Kini, Jagat NarulaEDITOR’S PAGE 115 Is It T1me for Tissue Characterization in Myocarditis?
Christopher M. Kramer, Y. Chandrashekhar, Jagat NarulaIMAGING COUNCIL
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118 Imaging at the 2014 ACC Legislative Conference: A DebriefPrem Soman, Rebecca Kelly
